Related Experiment Video
Updated: Sep 15, 2025
Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library
Published on: April 6, 2012
Integrated in silico and experimental screening identifies novel ligands that target precursor microRNA-31 at the
Grace Arhin1, Lily Haghpassand2, Sarah C Keane1,2
1Biophysics Program, University of Michigan.
Abstract:
MicroRNAs (miRNAs) regulate gene expression and the dysregulation in mature miRNA levels has been implicated in a wide variety of diseases. In particular, altered levels of mature microRNA-31 (miR-31) has been linked to a variety of different cancers. Targeting functionally relevant sites of the precursor structure of miR-31 with small molecules offer a strategy to regulate miR-31 maturation. Herein we describe a virtual screening approach to explore the druggability of the precursor structure of microRNA-31 (pre-miR-31). We used a structure-guided approach to virtually screen a fragment library and followed up with experimental characterization of top-ranking candidates, leading to the identification of several compounds that bound to pre-miR-31. Further characterization of the RNA-ligand complexes by heteronuclear single quantum coherence (HSQC) NMR spectroscopy revealed three compounds bound pre-miR-31 at the Dicer cleavage site, suggesting that these compounds may function to inhibit Dicer processing. Using these initial hits, we performed chemical structure similarity searches and identified additional binders of pre-miR-31 that had equivalent or enhanced binding relative to the parent compounds. These studies suggest a generalizable approach by which RNA-binding ligands can be identified from large chemical databases. These hits can then be further optimized to improve affinity and specificity for downstream functional assays.
Insights
Researchers identified small molecules that bind to microRNA-31 precursors, potentially inhibiting cancer-linked miR-31 maturation. This virtual screening approach offers a new strategy for developing RNA-targeting cancer therapeutics.
Area of Science:
- Molecular Biology
- Biochemistry
- Drug Discovery
Background:
- MicroRNAs (miRNAs) regulate gene expression, and their dysregulation is linked to various diseases, including cancer.
- Altered levels of microRNA-31 (miR-31) are specifically associated with several types of cancer.
- Targeting the precursor structure of miR-31 (pre-miR-31) with small molecules presents a strategy to modulate miR-31 maturation.
Purpose of the Study:
- To explore the druggability of the pre-miR-31 structure using a virtual screening approach.
- To identify small molecules that can bind to pre-miR-31.
- To investigate the potential of these molecules to inhibit miR-31 maturation.
Main Methods:
- Structure-guided virtual screening of a fragment library against pre-miR-31.
- Experimental characterization of top-ranking virtual screening candidates.
- Heteronuclear single quantum coherence (HSQC) NMR spectroscopy to analyze RNA-ligand complexes.
- Chemical structure similarity searches to identify additional binders.
Main Results:
- Several compounds were identified that bind to pre-miR-31.
- Three compounds were found to bind at the Dicer cleavage site of pre-miR-31.
- Additional binders with equivalent or enhanced binding affinity were identified through similarity searches.
Conclusions:
- The study demonstrates a generalizable virtual screening approach for identifying RNA-binding ligands from large chemical databases.
- The identified compounds show potential for inhibiting miR-31 maturation by targeting the Dicer cleavage site.
- These findings provide a foundation for developing novel RNA-targeting therapeutics for cancers associated with miR-31 dysregulation.
Related Concept Videos
02:15Experimental RNAi
01:22MicroRNAs
01:23RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
02:30siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...